This topic contains a solution. Click here to go to the answer

Author Question: With 370 mL remaining, a rate change to 68 mL/hr is ordered. It is 12:34 p.m. Calculate the infusion ... (Read 39 times)

tiffannnnyyyyyy

  • Hero Member
  • *****
  • Posts: 512
With 370 mL remaining, a rate change to 68 mL/hr is ordered. It is 12:34 p.m. Calculate the infusion time and the completion time.
 
  What will be an ideal response?

Question 2

A bolus dose of heparin is given to
 
  A. increase the patients clotting time.
  B. more quickly reach the maximum dose.
  C. achieve a therapeutic blood level of heparin.
  D. decrease the toxicity of heparin.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Kdiggy

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

5.4 hours; 5:58 p.m.
5 hours 24 minutes; 5:58 p.m.

Infusion time is 5.4 hours, or 5 hours 24 minutes.
Completion time is 5:58 p.m.

Answer to Question 2

C




tiffannnnyyyyyy

  • Member
  • Posts: 512
Reply 2 on: Jul 3, 2018
YES! Correct, THANKS for helping me on my review


hollysheppard095

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library